BAY 94‐9027 Prophylaxis Is Efficacious and Well Tolerated for Up to >5 Years With Extended Dosing Intervals: PROTECT VIII Extension Interim Results

Haemophilia - United Kingdom
doi 10.1111/hae.13853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Factor VIII Activity of BAY 94-9027 Is Accurately Measured With Most Commonly Used Assays: Results From an International Laboratory Study

Haemophilia
MedicineGeneticsHematology
2018English

Issues Complicating Precision Dosing for Factor VIII Prophylaxis

Transfusion and Apheresis Science
Hematology
2018English

Subcutaneous Treprostinil Is Well Tolerated With Infrequent Site Changes and Analgesics

Pulmonary Circulation
PulmonaryRespiratory Medicine
2013English

Intra-Seasonal Short-Time Up-Dosing With SQ-Standardised Subcutaneous Immunotherapy in Patients With Intermittent Allergic Rhinoconjunctivitis Is Well Tolerated During Routine Application: A Non-Interventional, Observational Study

Journal of Allergy & Therapy
2013English

Imepitoin Is Well Tolerated in Healthy and Epileptic Cats

BMC Veterinary Research
MedicineVeterinary
2017English

Continued Benefit Demonstrated With BAY 81-8973 Prophylaxis in Previously Treated Children With Severe Haemophilia A: Interim Analysis From the LEOPOLD Kids Extension Study

Thrombosis Research
Hematology
2020English

Sertraline Was Effective and Well Tolerated for Generalised Social Phobia

Evidence-Based Mental Health
PsychiatryMental Health
2001English

Epacadostat Plus Pembrolizumab Is Well Tolerated in a Phase I Trial

Cancer Discovery
Oncology
2018English

A Single Dose of Donor Lymphocytes Depleted of Alloreactive T Cells (ATIR101) After Haploidentical HSCT Is Well-Tolerated and Efficacious: Pooled Analysis of Two Phase II Studies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy